Sotalol for Ventricular Tachyarrhythmias: Beta-Blocking and Class III Contributions, and Relative Efficacy Versus Class I Drugs After Prior Drug Failure

This publication has 10 references indexed in Scilit:

• Influence of holter monitor and electrophysiologic study methods and efficacy criteria on the outcome of patients with ventricular tachycardia and ventricular fibrillation in the ESVEM trial
  Progress in Cardiovascular Diseases, 1996
• Cardiologists' practices compared with practice guidelines: Use of beta-blockade after acute myocardial infarction
  Journal of the American College of Cardiology, 1995
• Predictors of mortality in patients with sustained ventricular tachycardias or ventricular fibrillation and depressed left ventricular function: Importance of β-blockade
  American Heart Journal, 1995
• Insights into the electrophysiology study versus electrocardiographic monitoring trial: Its programmed stimulation protocol may introduce bias when assessing long-term antiarrhythmic drug therapy
  Journal of the American College of Cardiology, 1995
• Choosing the Right β-Blocker
  Drugs, 1994
• Safety and efficacy of oral sotalol for sustained ventricular tachyarrhythmias refractory to other antiarrhythmic agents
  The American Journal of Cardiology, 1993
• A Comparison of Seven Antiarrhythmic Drugs in Patients with Ventricular Tachyarrhythmias
  New England Journal of Medicine, 1993
• A Comparison of Electrophysiologic Testing with Holter Monitoring to Predict Antiarrhythmic-Drug Efficacy for Ventricular Tachyarrhythmias
  New England Journal of Medicine, 1993
• Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE study)
  The American Journal of Cardiology, 1993
• Beta-adrenergic blockers as cardioprotective agents
  The American Journal of Cardiology, 1992